Everest Medicines Announces Taiwan TFDA Approval of NEFECON for the Treatment of Primary IgA Nephropathy
SHANGHAI, Oct 21, 2src24 - (ACN Newswire) - Everest Medicines (HKEX 1952.HK, “Everest”, or the “Company”), a biopharmaceutical company focused...
